Protein detail

ACHA2

Neuronal acetylcholine receptor subunit alpha-2 (Nicotinic acetylcholine receptor subunit alpha-2)

Entry name
ACHA2
UniProt ID
EVMP confidence score
0.50
Supporting publications (n)
1
Transmembrane count
4
Protein classification
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information8
Protein Names
Neuronal acetylcholine receptor subunit alpha-2 (Nicotinic acetylcholine receptor subunit alpha-2)
Protein Function (4)
  • Human disease related genes:Nervous system diseases:Epilepsy
  • Disease related genes
  • FDA approved drug targets:Small molecule drugs
  • Predicted intracellular proteins
Transmembrane
265..289; Helical; 297..315; Helical; 331..352; Helical; 503..521; Helical
Transmembrane Count
4
Entrez Gene Symbol
Supporting publications (n)
1
EVMP confidence score
0.50
Function & Pathway7
Protein Function (4)
  • Human disease related genes:Nervous system diseases:Epilepsy
  • Disease related genes
  • FDA approved drug targets:Small molecule drugs
  • Predicted intracellular proteins
Mediation Categories (3)
Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation
Relations & Evidence40

Ligand-Receptor Signaling (36)

36 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
receptorreceptorHGNCNoYesNoNoNo
receptorreceptorCellPhoneDBNoYesNoNoNo
receptorreceptorCellChatDBNoYesNoNoNo
gaba_achreceptorAlmen2009NoYesNoNoNo
receptorreceptorOmniPathNoYesNoNoNo
extracellularextracellularLOCATENoNoNoNoNo
extracellularextracellularOmniPathNoNoNoNoNo
intracellularintracellularLOCATENoNoNoNoNo
intracellularintracellularOmniPathNoNoNoNoNo
intracellularintracellularGO_IntercellNoNoNoNoNo
Page 1 of 4Next

Protein Complex Composition (4)

4 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
AcetylcholineReceptor_a2b3CHRNA2CHRNB3Q05901Q158221:1CellPhoneDBCellPhoneDB:AcetylcholineReceptor_a2b3
CHRNA2-CHRNB4 complexCHRNA2CHRNB4P30926Q158221:1CORUMComplexPortalCORUM:6440intact:EBI-9009014254601851949841722309577103539888906617194810631475529219126755
Neuronal nicotinic acetylcholine receptor complexalpha2-beta2CHRNA2CHRNB2P17787Q158221:1ComplexPortalintact:EBI-900861725460185223095771090829710353988194810631475529219126755
CHRNA2Q158225PDBPDB:5fjv
Sequence, Structure & Domains12

Sequences

Length
529
Mass
59,765
Sequence
MGPSCPVFLSFTKLSLWWLLLTPAGGEEAKRPPPRAPGDPLSSPSPTALPQGGSHTETEDRLFKHLFRGYNRWARPVPNTSDVVIVRFGLSIAQLIDVDEKNQMMTTNVWLKQEWSDYKLRWNPTDFGNITSLRVPSEMIWIPDIVLYNNADGEFAVTHMTKAHLFSTGTVHWVPPAIYKSSCSIDVTFFPFDQQNCKMKFGSWTYDKAKIDLEQMEQTVDLKDYWESGEWAIVNATGTYNSKKYDCCAEIYPDVTYAFVIRRLPLFYTINLIIPCLLISCLTVLVFYLPSDCGEKITLCISVLLSLTVFLLLITEIIPSTSLVIPLIGEYLLFTMIFVTLSIVITVFVLNVHHRSPSTHTMPHWVRGALLGCVPRWLLMNRPPPPVELCHPLRLKLSPSYHWLESNVDAEEREVVVEEEDRWACAGHVAPSVGTLCSHGHLHSGASGPKAEALLQEGELLLSPHMQKALEGVHYIADHLRSEDADSSVKEDWKYVAMVIDRIFLWLFIIVCFLGTIGLFLPPFLAGMI
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=Q15822-1; Sequence=Displayed; Name=2; IsoId=Q15822-2; Sequence=VSP_055156
Alternative Sequence
82..96; Missing (in isoform 2)

3D Structural Models

Turn
100..103; 124..129; 137..139; 148..150; 167..169; 208..210; 217..219
Helix
61..69; 118..120
Beta Strand
74..76; 78..82; 84..99; 104..116; 131..136; 145..147; 162..166; 170..173; 176..182; 190..192; 198..205; 211..215; 237..245; 248..258
3D Structure
X-ray crystallography (1)

Domain & Motif Annotations

Region
27..56; Disordered
Protein Families (3)
  • Ligand-gated ion channel (TC 1.A.9) family
  • Acetylcholine receptor (TC 1.A.9.1) subfamily
  • Alpha-2/CHRNA2 sub-subfamily
Sequence Similarities
Belongs to the ligand-gated ion channel (TC 1.A.9) family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-2/CHRNA2 sub-subfamily.
Clinical Relevance3
Supporting Publications1
PMIDTitleAbstract
29045505Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.Proteomic analysis of the exosome 'surfaceome' revealed multiple PDAC-specific biomarker candidates: CLDN4, EPCAM, CD151, LGALS3BP, HIST2H2BE, and HIST2H2BF. Droplet digital PCR was used on 74 patients (136 total exosome samples) to determine baseline KRAS mutation call rates while patients were on therapy. KRAS mutations in total exosomes were detected in 44.1% of patients undergoing active therapy compared with 73.0% following exosome capture using the selected biomarkers.